Summary:
Evanston Premier Healthcare Research is conducting an 8 week study with 2 visits comparing an investigational medication to placebo in patients who get frequent migraines. There is a 52 week open label extension study which is optional and does not have a placebo.
Qualified Participants Must:
•
Have 3-8 migraines per month
•
Be willing to use a highly effective birth control method if female
•
Have been experiencing migraines for at least one year and onset before the age of 50
Qualified Participants May Receive:
Compensation for time and travel.